Please login to the form below

Not currently logged in
Email:
Password:

Fotivda

This page shows the latest Fotivda news and features for those working in and with pharma, biotech and healthcare.

Aveo’s tivozanib is knocked back by FDA once again

Aveo’s tivozanib is knocked back by FDA once again

EMA to approve the drug as Fotivda in Europe in 2017 based on the TIVO-1 data. ... Fast forward a few years , and Fotivda’s license in Europe is at risk of being  withdrawn, and the company’s attempt to file in the US based on TIVO-3

Latest news

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...